Visceral adipose tissue is significantly associated with hearing thresholds in adult women

Clinical Endocrinology

Volumn 80, Issue 3, 2014, Pages 368-375

  Kim, Tae Su ^a   Park, Sung Won ^a   Kim, Do Yeon ^a   Kim, Eon Bin ^a   Chung, Jong Woo ^a   So, Hong Seob ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; AUDITORY THRESHOLD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SEX DIFFERENCE; VERY ELDERLY;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; AUDITORY THRESHOLD; BODY MASS INDEX; FEMALE; HEARING; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897838038     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12184     Document Type: Article

References (33)

1. Seidman, M.D., Ahmad, N. & Bai, U. (2002) Molecular mechanisms of age-related hearing loss. Ageing Research Reviews, 1, 331-343.
2. Woo, K.J. (2012) Population Projections for Korea: 2010-2060 (Based on the 2010 Census). Korea Statistics Promotion Institute (KR). 38-40. Report No.:11-1240000-000125-13.
3. Bai, U., Seidman, M.D., Hinojosa, R. et al. (1997) Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. American Journal of Otology, 18, 449-453.
4. Schuknecht, H.F. (1964) Further observations on the pathology of presbycusis. Archives of Otolaryngology, 80, 369-382.
5. Schuknecht, H.F. & Gacek, M.R. (1993) Cochlear pathology in presbycusis. The Annals of Otology, Rhinology, and Laryngology, 102, 1-16.
6. Friedland, D.R., Cederberg, C. & Tarima, S. (2009) Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk. The Laryngoscope, 119, 473-486.
7. Bainbridge, K.E., Hoffman, H.J. & Cowie, C.C. (2011) Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999-2004. Diabetes Care, 34, 1540-1545.
8. Fransen, E., Topsakal, V., Hendrickx, J.J. et al. (2008) Occupational noise, smoking, and a high body mass index are risk factors for age-related hearing impairment and moderate alcohol consumption is protective: a European population-based multicenter study. Journal of the Association for Research in Otolaryngology, 9, 264-276.
9. Hwang, J.H., Wu, C.C., Hsu, C.J. et al. (2009) Association of central obesity with the severity and audiometric configurations of age-related hearing impairment. Obesity (Silver Spring), 17, 1796-1801.
10. Fox, C.S., Massaro, J.M., Hoffmann, U. et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation, 116, 39-48.
11. Ibrahim, M.M. (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Reviews, 11, 11-18.
12. Oka, R., Miura, K., Sakurai, M. et al. (2010) Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring), 18, 153-160.
13. Cueva, R.A. (2004) Auditory brainstem response versus magnetic resonance imaging for the evaluation of asymmetric sensorineural hearing loss. The Laryngoscope, 114, 1686-1692.
14. Chung, S.J., Kim, D., Park, M.J. et al. (2008) Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut, 57, 1360-1365.
15. Committee on Hearing (1995) Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. Otolaryngology - Head and Neck Surgery, 113, 186-187.
16. Alberti, K.G., Zimmet, P. & Shaw, J. (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480.
17. Ahima, R.S. (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring), 14(Suppl 5), 242S-249S.
18. Hwang, J.H., Hsu, C.J., Liu, T.C. et al. (2011) Association of plasma adiponectin levels with hearing thresholds in adults. Clinical Endocrinology, 75, 614-620.
19. Yang, W.S., Lee, W.J., Funahashi, T. et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Journal of Clinical Endocrinology and Metabolism, 86, 3815-3819.
20. Chu, S.H., Lee, M.K., Ahn, K.Y. et al. (2012) Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS ONE, 7, e34710.
21. Pou, K.M., Massaro, J.M., Hoffmann, U. et al. (2007) Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation, 116, 1234-1241.
22. Misra, A., Garg, A., Abate, N. et al. (1997) Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obesity Research, 5, 93-99.
23. Tanko, L.B., Bagger, Y.Z., Alexandersen, P. et al. (2003) Peripheral adiposity exhibits an independent dominant anti-atherogenic effect in elderly women. Circulation, 107, 1626-1631.
24. Baglioni, S., Cantini, G., Poli, G. et al. (2012) Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS ONE, 7, e36569.
25. Frisina, S.T., Mapes, F., Kim, S. et al. (2006) Characterization of hearing loss in aged type II diabetics. Hearing Research, 211, 103-113.
26. Pickles, J.O. (2004) Mutation in mitochondrial DNA as a cause of presbyacusis. Audiology & Neuro-otology, 9, 23-33.
27. Dai, P., Yang, W., Jiang, S. et al. (2004) Correlation of cochlear blood supply with mitochondrial DNA common deletion in presbyacusis. Acta Oto-Laryngologica, 124, 130-136.
28. Satar, B., Ozkaptan, Y., Surucu, H.S. et al. (2001) Ultrastructural effects of hypercholesterolemia on the cochlea. Otology & Neurotology, 22, 786-789.
29. Parlee, S.D., Ernst, M.C., Muruganandan, S. et al. (2010) Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-a. Endocrinology, 151, 2590-2602.
30. Bruun, J.M., Lihn, A.S., Verdich, C. et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology, Endocrinology and Metabolism, 285, E527-E533.
31. Stanley, T.L., Zanni, M.V., Johnsen, S. et al. (2011) TNF-a antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 96, E146-E150.
32. Trujillo, M.E. & Scherer, P.E. (2005) Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine, 257, 167-175.
33. Shin, H.Y., Lee, D.C., Chu, S.H. et al. (2011) Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clinical Endocrinology, 77, 47-50.